![Safety | Free Full-Text | When the Tension Is Rising: A Simulation-Based Study on the Effects of Safety Incentive Programs and Behavior-Based Safety Management | HTML Safety | Free Full-Text | When the Tension Is Rising: A Simulation-Based Study on the Effects of Safety Incentive Programs and Behavior-Based Safety Management | HTML](https://www.mdpi.com/safety/safety-07-00009/article_deploy/html/images/safety-07-00009-g001-550.jpg)
Safety | Free Full-Text | When the Tension Is Rising: A Simulation-Based Study on the Effects of Safety Incentive Programs and Behavior-Based Safety Management | HTML
![Table of vaccines for influenza (flu) with a valid marketing authorisation - Seasonal Influenza 2019/2020 - Paul-Ehrlich-Institut Table of vaccines for influenza (flu) with a valid marketing authorisation - Seasonal Influenza 2019/2020 - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/DE/arzneimittel/Influenza/2019-2020-influenza-dosen.jpg?__blob=poster&v=2)
Table of vaccines for influenza (flu) with a valid marketing authorisation - Seasonal Influenza 2019/2020 - Paul-Ehrlich-Institut
![BoSaibot 🟢 on Twitter: "@AlistairHaimes In Germany we have a" Rhino virus pandamic"! (blue graph)....mask effectiveness??? SARS 2 is no more detectable in our sentinel samples (200 registrated medical offices) Source RKI BoSaibot 🟢 on Twitter: "@AlistairHaimes In Germany we have a" Rhino virus pandamic"! (blue graph)....mask effectiveness??? SARS 2 is no more detectable in our sentinel samples (200 registrated medical offices) Source RKI](https://pbs.twimg.com/media/EhyQi5PXsAELh7X.jpg)
BoSaibot 🟢 on Twitter: "@AlistairHaimes In Germany we have a" Rhino virus pandamic"! (blue graph)....mask effectiveness??? SARS 2 is no more detectable in our sentinel samples (200 registrated medical offices) Source RKI
![Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data - The Lancet Regional Health – Europe Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data - The Lancet Regional Health – Europe](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ce546a21-d16b-4dc0-acdf-4664d0cf210a/gr3_lrg.jpg)